Search

The developing countries are still starving for the betterment of health sector. The disease commonly found among the women is breast cancer, and past researches have proven results that if the cancer is detected at a very early stage, the chances to overcome the disease are higher than the disease treated or detected at a later stage. This article proposed cloud-based intelligent BCP-T1F-SVM with 2 variations/models like BCP-T1F and BCP-SVM. The proposed BCP-T1F-SVM system has employed two main soft computing algorithms. The proposed BCP-T1F-SVM expert system specifically defines the stage and the type of cancer a person is suffering from. Expert system will elaborate the grievous stages of the cancer, to which extent a patient has suffered. The proposed BCP-SVM gives the higher precision of the proposed breast cancer detection model. In the limelight of breast cancer, the proposed BCP-T1F-SVM expert system gives out the higher precision rate. The proposed BCP-T1F expert system is being employed in the diagnosis of breast cancer at an initial stage. Taking different stages of cancer into account, breast cancer is being dealt by BCP-T1F expert system. The calculations and the evaluation done in this research have revealed that BCP-SVM is better than BCP-T1F. The BCP-T1F concludes out the 96.56 percentage accuracy, whereas the BCP-SVM gives accuracy of 97.06 percentage. The above unleashed research is wrapped up with the conclusion that BCP-SVM is better than the BCP-T1F. The opinions have been recommended by the medical expertise of Sheikh Zayed Hospital Lahore, Pakistan, and Cavan General Hospital, Lisdaran, Cavan, Ireland.

In this research, a new multilayered mamdani fuzzy inference system (Ml-MFIS) is proposed to diagnose hepatitis B. The proposed automated diagnosis of hepatitis B using multilayer mamdani fuzzy inference system (ADHB-ML-MFIS) expert system can classify the different stages of hepatitis B such as no hepatitis, acute HBV, or chronic HBV. The expert system has two input variables at layer I and seven input variables at layer II. At layer I, input variables are ALT and AST that detect the output condition of the liver to be normal or to have hepatitis or infection and/or other problems. The further input variables at layer II are HBsAg, anti-HBsAg, anti-HBcAg, anti-HBcAg-IgM, HBeAg, anti-HBeAg, and HBV-DNA that determine the output condition of hepatitis such as no hepatitis, acute hepatitis, or chronic hepatitis and other reasons that arise due to enzyme vaccination or due to previous hepatitis infection. This paper presents an analysis of the results accurately using the proposed ADHB-ML-MFIS expert system to model the complex hepatitis B processes with the medical expert opinion that is collected from the Pathology Department of Shalamar Hospital, Lahore, Pakistan. The overall accuracy of the proposed ADHB-ML-MFIS expert system is 92.2%.